Who We Are?

Who is Dr. Nieusma?

Dr. Nieusma is our fearless CEO/Chief Toxicologist here at Superior Toxicology & Wellness. We are an international scientific consulting firm. Dr. Nieusma is also a co-founder for TwinOxide North America. Which is a company working to improve water quality in all aspects of life from municipal treatment plants to livestock operations.

What About Any Boards Dr. Nieusma On?

Dr. Nieusma is a member of the Scientific Advisory Board for Vitro Biopharma, a firm that brings new stem-cell related products for diabetes research to scientific, pharmaceutical, and ultimately medical markets.  Dr. Nieusma is also on the editorial staff for the peer-reviewed scientific journal, Toxicology Mechanisms and Methods, published by Informa Healthcare.

As a member of the Society of Toxicology, which requires nomination and membership, is based on scientific expertise in the field.  Dr. Nieusma has served as a lecturer for the Toxicology and Occupational Health Course at the University of Colorado Graduate School, the American Industrial Hygiene Association and for the conference for “Environmental, Health and Safety for the Life Science Industry”. Dr. Nieusma’s qualifications are described in detail in his curriculum vitae which has been provided.

What About Dr. Nieusma’s Background?

Dr. Nieusma earned his B.S. from Central Michigan University with a major in pre-med biology and a minor in chemistry.  He went on to earn a Ph.D. in Pharmaceutical Sciences from the University of Colorado, School of Pharmacy and the Molecular Toxicology and Environmental Health Sciences Program.  The title of his dissertation research is “Stereochemical aspects of 1,3-Butadiene Metabolism and Toxicity”. His research characterized the very different pattern of metabolism and toxicity mainly due to the orientation of various side chains around chiral carbons of a small molecule hydrocarbon with multiple double bonds.

Dr. Nieusma was a Senior Toxicologist for Affygility Solutions from October 2005 to February 2018. Dr. Nieusma has participated as an editorial board member for Micromedex, Inc. since May of 2001 primarily to provide toxicological evaluation of potential new products and databases as needed.  Dr. Nieusma has participated in research for a human health risk assessment involving over 100 chemicals of interest from a US Naval incinerator in Osaka, Japan. Dr. Nieusma worked for Dow Chemical in the Biotransformation group from September 1989 until July 1991.

Dr. Nieusma has completed over 1500 drug monographs which highlighted potency, adverse effects, cumulative effects and developmental or reproductive effects of these pharmaceutical agents. Through his experience, professional judgment and knowledge of the drug, he formulates an opinion as to whether a certain effect is possibly due to exposure to a pharmaceutical agent in question. On a regular basis Dr. Nieusma is asked to review specific jobs in specific environments with multiple potential exposures to drugs, chemicals, and excipients for potential reproductive hazards of occupational exposure.